The global pediatric healthcare market size is calculated at USD 15.77 billion in 2025 and is forecasted to reach around USD 32.48 billion by 2034, accelerating at a CAGR of 6.52% from 2025 to 2034. The North America market size surpassed USD 5.97 billion in 2024 and is expanding at a CAGR of 8.49% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pediatric Healthcare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pediatric Healthcare Market Revenue and Volume, by Type of Diseases
8.1.1 Short Term Diseases
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Chronic Diseases
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Others
8.1.3.1. Market Revenue and Volume Forecast
9.1. Pediatric Healthcare Market Revenue and Volume, by Therapeutics
9.1.1. Cardiology
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Allergy and Immunology
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Gastroenterology
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Infectious Disease
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Volume Forecast
10.1. Pediatric Healthcare Market Revenue and Volume, by Treatment
10.1.1. Medication- Dominating
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Surgery- Fastest Growing
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Others
10.1.3.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Type of Diseases
11.1.2. Market Revenue and Volume Forecast, by Therapeutics
11.1.3. Market Revenue and Volume Forecast, by Treatment
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Type of Diseases
11.1.4.2. Market Revenue and Volume Forecast, by Therapeutics
11.1.4.3. Market Revenue and Volume Forecast, by Treatment
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Type of Diseases
11.1.5.2. Market Revenue and Volume Forecast, by Therapeutics
11.1.5.3. Market Revenue and Volume Forecast, by Treatment
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Type of Diseases
11.2.2. Market Revenue and Volume Forecast, by Therapeutics
11.2.3. Market Revenue and Volume Forecast, by Treatment
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Type of Diseases
11.2.4.2. Market Revenue and Volume Forecast, by Therapeutics
11.2.4.3. Market Revenue and Volume Forecast, by Treatment
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Type of Diseases
11.2.5.2. Market Revenue and Volume Forecast, by Therapeutics
11.2.5.3. Market Revenue and Volume Forecast, by Treatment
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Type of Diseases
11.2.6.2. Market Revenue and Volume Forecast, by Therapeutics
11.2.6.3. Market Revenue and Volume Forecast, by Treatment
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Type of Diseases
11.2.7.2. Market Revenue and Volume Forecast, by Therapeutics
11.2.7.3. Market Revenue and Volume Forecast, by Treatment
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Type of Diseases
11.3.2. Market Revenue and Volume Forecast, by Therapeutics
11.3.3. Market Revenue and Volume Forecast, by Treatment
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Type of Diseases
11.3.4.2. Market Revenue and Volume Forecast, by Therapeutics
11.3.4.3. Market Revenue and Volume Forecast, by Treatment
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Type of Diseases
11.3.5.2. Market Revenue and Volume Forecast, by Therapeutics
11.3.5.3. Market Revenue and Volume Forecast, by Treatment
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Type of Diseases
11.3.6.2. Market Revenue and Volume Forecast, by Therapeutics
11.3.6.3. Market Revenue and Volume Forecast, by Treatment
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Type of Diseases
11.3.7.2. Market Revenue and Volume Forecast, by Therapeutics
11.3.7.3. Market Revenue and Volume Forecast, by Treatment
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Type of Diseases
11.4.2. Market Revenue and Volume Forecast, by Therapeutics
11.4.3. Market Revenue and Volume Forecast, by Treatment
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Type of Diseases
11.4.4.2. Market Revenue and Volume Forecast, by Therapeutics
11.4.4.3. Market Revenue and Volume Forecast, by Treatment
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Type of Diseases
11.4.5.2. Market Revenue and Volume Forecast, by Therapeutics
11.4.5.3. Market Revenue and Volume Forecast, by Treatment
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Type of Diseases
11.4.6.2. Market Revenue and Volume Forecast, by Therapeutics
11.4.6.3. Market Revenue and Volume Forecast, by Treatment
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Type of Diseases
11.4.7.2. Market Revenue and Volume Forecast, by Therapeutics
11.4.7.3. Market Revenue and Volume Forecast, by Treatment
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Type of Diseases
11.5.2. Market Revenue and Volume Forecast, by Therapeutics
11.5.3. Market Revenue and Volume Forecast, by Treatment
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Type of Diseases
11.5.4.2. Market Revenue and Volume Forecast, by Therapeutics
11.5.4.3. Market Revenue and Volume Forecast, by Treatment
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Type of Diseases
11.5.5.2. Market Revenue and Volume Forecast, by Therapeutics
11.5.5.3. Market Revenue and Volume Forecast, by Treatment
12.1. Novartis AG (Switzerland),
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. AstraZeneca (UK),
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Janssen Services,
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. LLC (Belgium),
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Eli Lilly and Company (US),
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Bristol-Myers Squibb Company (US),
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. AMMT (Dubai),
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. King Faisal Specialist Hospital and Research Centre (Saudi Arabia),
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. VPS Healthcare (UAE), and
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Others
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description